Global Trust Asset Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Global Trust Asset Management, LLC
- $234 Million
- Q4 2025
A detailed history of Global Trust Asset Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 60 shares of ALNY stock, worth $26,949. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60
Previous 60
-0.0%
Holding current value
$26,949
Previous $27,000
3.7%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
926Shares Held
117MCall Options Held
1.25MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...